Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G49108TO
Summary
- GlyTouCan ID
-
G49108TO
- IUPAC Condensed
- GlcNAc(b1-
External Links
- GlyConnect structure
- GlyGen
- ChEBI
- PubChem Compound
- PubChem Substance
- The Human Metabolome Database
- CarbBank
-
- 9
- 3780
- 3968
- 4708
- 25653
- 28493
- 29021
- 29527
- 29549
- 31775
- 32028
- 32903
- 33539
- 36048
- 36270
- 37035
- 37525
- 37675
- 37677
- 37678
- 39452
- 39454
- 39456
- 39609
- 39611
- 39613
- 39614
- 40149
- 40150
- 40151
- 40355
- 40591
- 40600
- 42059
- 42207
- 42220
- 43184
- 43893
- 43925
- 43926
- 43931
- 43932
- 43941
- 44395
- 44396
- 44397
- 44549
- 46453
- 47268
- 47468
- 47537
- 47603
- 47796
- 48630
- 48812
- 48813
- 49006
- 49732
- 50589
- 50736
3D Structures
- GLYCAM
- DGlcpNAcb1-OH
G14843DJ
G68544GH
Organisms
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) | |
| Drosophila melanogaster (fruit fly) | |
| Streptococcus pneumoniae |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT2 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT1 | UDP-Gal |
G49108TO
|
R |
G00055MO
|
R | |
| B3GALT5 | UDP-Gal |
G49108TO
|
R |
G00056MO
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-Benzl |
G00055MO
|
[beta]-1-Benzl | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-4-methyl-umbelliferyl |
G00055MO
|
[beta]-1-4-methyl-umbelliferyl |
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| O75044 | SLIT-ROBO Rho GTPase-activating protein 2 | ||
| O75071 | EF-hand calcium-binding domain-containing protein 14 | ||
| O75094 | Slit homolog 3 protein | ||
| O75096 | Low-density lipoprotein receptor-related protein 4 | ||
| O75113 | NEDD4-binding protein 1 | ||
| O75116 | Rho-associated protein kinase 2 | ||
| O75122 | CLIP-associating protein 2 | ||
| O75131 | Copine-3 | ||
| O75132 | Zinc finger BED domain-containing protein 4 | ||
| O75140 | GATOR1 complex protein DEPDC5 |
GlycoEpitope
- Epitope ID
- EP0004
Pathway
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Xenopus tropicalis |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Danio rerio |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Homo sapiens |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38040762 | Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8 | Sun D | 2023 Dec 01 |
|
| 38040419 | Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions | Lameris R | 2023 Dec 01 |
|
| 37944617 | A novel family of sugar-specific phosphodiesterases that remove zwitterionic modifications of GlcNAc | Fossa SL | 2023 Dec |
|
| 37918804 | Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases | Pratt MR | 2023 Dec |
|
| 37832852 | Engineering Corynebacterium glutamicum for the efficient production of N-acetylglucosamine | Li Z | 2023 Dec |
|
| 37852477 | Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys | Fenwick C | 2023 Dec |
|
| 37949223 | Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity | Narayanan B | 2023 Dec |
|
| 37354972 | Follicular cells protect Xenopus oocyte from abnormal maturation via integrin signaling downregulation and O-GlcNAcylation control | Martoriati A | 2023 Aug |
|
| 37196774 | O-GlcNAcylation enhances Reticulon 2 protein stability and its promotive effects on gastric cancer progression | Wang G | 2023 Aug |
|
| 37653170 | Motif-dependent binding on the intervening domain regulates O-GlcNAc transferase | Blankenship CM | 2023 Aug 31 |
|
PubAnnotation
